Generic Zoloft Approved

Among top-selling U.S. drugs

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

WEDNESDAY, July 5, 2006 (HealthDay News) -- The first generic versions of the popular antidepressant Zoloft (sertraline) have been approved by the U.S. Food and Drug Administration.

Last year, Pfizer's Zoloft was the sixth-best selling drug in the United States with retail sales of more than $2.5 billion, the agency said in a statement. The company's patent expired last week.

Israeli generic drugmaker Teva Pharmaceuticals plans to launch its version of Zoloft later this month, the Associated Press reported.

Generics, less expensive than brand-name equivalents, accounted for about two-thirds of U.S. prescription drug sales in 2004, the FDA said.

More information

For more information about Zoloft, visit the National Library of Medicine.


Last Updated: